Giovanna Poce

Rome, 00185, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Targeting Fusobacterium nucleatum in cancer therapy: A new frontier in solid tumor treatment.

Targeting Fusobacterium nucleatum in cancer therapy: A new frontier in solid tumor treatment.

Journal: European journal of medicinal chemistry
Published: March 31, 2026

Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors.

Structure-Activity relationship and optimization of drug-like properties of antituberculosis 3-(4,4-dimethyl-1,4-azasilinane)methylpyrazole MmpL3 inhibitors.

Journal: European journal of medicinal chemistry
Published: January 26, 2026

In vivo screen of Plasmodium targets for mosquito-based malaria control.

In vivo screen of Plasmodium targets for mosquito-based malaria control.

Journal: Nature
Published: March 29, 2025

Mycobacterium tuberculosis inhibitors: an updated patent review (2021-present).

Mycobacterium tuberculosis inhibitors: an updated patent review (2021-present).

Journal: Expert opinion on therapeutic patents
Published: October 21, 2024

Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA.

Lipopeptide antibiotics disrupt interactions of undecaprenyl phosphate with UptA.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 03, 2024

SAR Analysis of Novel Coxsackie virus A9 Capsid Binders.

SAR Analysis of Novel Coxsackie virus A9 Capsid Binders.

Journal: Journal of medicinal chemistry
Published: September 18, 2024

Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development.

Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 11, 2024

Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery.

Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery.

Journal: Pharmaceutics
Published: April 19, 2024

Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9.

Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9.

Journal: Pharmaceutics
Published: February 15, 2023

Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.

Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 21, 2022

Malaria transmission blocking compounds: a patent review.

Malaria transmission blocking compounds: a patent review.

Journal: Expert opinion on therapeutic patents
Published: March 04, 2022

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment.

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment.

Journal: Pharmaceutics
Published: January 31, 2022
Showing 1-12 of 45

Last Updated: 09/26/2026